Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Express Scripts
Cipla
McKesson
UBS
Citi
Chinese Patent Office
Harvard Business School
McKinsey

Generated: April 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 065220

« Back to Dashboard

NDA 065220 describes NEOMYCIN SULFATE, which is a drug marketed by Breckenridge Pharm, Bristol Myers Squibb, Lannett, Lannett Holdings Inc, Lilly, Roxane, Sandoz, Teva, X Gen Pharms, Bausch And Lomb, Pharmafair, Alcon Pharms Ltd, Fougera, and Pharmaderm, and is included in twenty NDAs. It is available from five suppliers. Additional details are available on the NEOMYCIN SULFATE profile page.

The generic ingredient in NEOMYCIN SULFATE is neomycin sulfate; triamcinolone acetonide. There are nineteen drug master file entries for this compound. Additional details are available on the neomycin sulfate; triamcinolone acetonide profile page.
Summary for 065220
Tradename:NEOMYCIN SULFATE
Applicant:X Gen Pharms
Ingredient:neomycin sulfate
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Pharmacology for NDA: 065220
Ingredient-typeAminoglycosides
Medical Subject Heading (MeSH) Categories for 065220
Suppliers and Packaging for NDA: 065220
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NEOMYCIN SULFATE neomycin sulfate TABLET;ORAL 065220 ANDA X-GEN Pharmaceuticals, Inc. 39822-0310 N 39822-0310-5
NEOMYCIN SULFATE neomycin sulfate TABLET;ORAL 065220 ANDA Hi-Tech Pharmacal 50383-565 N 50383-565-10

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength500MG
Approval Date:Jul 28, 2006TE:AARLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
UBS
Daiichi Sankyo
Teva
US Army
Cipla
Healthtrust
Medtronic
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.